Pet Probiotics and Postbiotics Market Forecasts to 2034 - Global Analysis By Product Type, Health Application, Pet Type, Product Format, Microbial and Active Source, Evidence Positioning, Distribution Channel, and By Geography

According to Stratistics MRC, the Global Pet Probiotics and Postbiotics Market is accounted for $0.6 billion in 2026 and is expected to reach $1.1 billion by 2034 growing at a CAGR of 7.9% during the forecast period. The market covers microbial and microbial-derived products used to support companion-animal gut and related health, including live probiotic strains and postbiotic metabolites. It is used to support digestive balance and complement veterinary management of selected gastrointestinal needs. Growth reflects research into the pet microbiome and greater interest in evidence-led functional nutrition. Further uptake will be shaped by technology readiness, customer confidence, pricing and the breadth of service networks.

Market Dynamics:

Driver:

Interest in the pet microbiome and targeted digestive support

Growing research into the pet microbiome and owner interest in evidence-led functional nutrition are driving the probiotics and postbiotics market. Products support digestive balance, stool quality, immune function and recovery after stress or antibiotics. Veterinarians recommend strain-specific probiotics for gastrointestinal needs. Postbiotics offer stability advantages and new formulation options. Premiumization, e-commerce and subscription models expand access. Humanization and demand for preventive gut health support sustained growth across dogs and cats.

Restraint:

Strain-specific evidence and product stability requirements

Adoption is constrained by the need for strain-specific evidence and product stability. Many products lack clinical validation, and viability can decline during storage and shipping. Labeling often omits strain and CFU details, complicating comparison. Veterinarians may hesitate to recommend unverified products. Regulatory oversight varies between supplements and therapeutics. Price sensitivity and competition from generic products pressure margins. Clear strain documentation, stability testing and clinical evidence are essential.

Opportunity:

Targeted formulations and stronger clinical evidence

Opportunity lies in targeted formulations for digestive, immune and recovery needs, supported by strain-specific clinical evidence. Postbiotics and synbiotic blends offer differentiation. Veterinary-channel products and prescription adjuncts command trust and premium pricing. Subscription and bundle formats improve adherence. Partnerships with clinics, breeders and insurers expand reach. Education on strain specificity and proper storage supports appropriate use. Regional expansion and localized formulations address diverse market needs.

Threat:

Quality variation and overstated health claims

The market faces risks from quality variation, viability failures and overstated health claims. Products with inaccurate CFU counts or unlisted strains can harm trust. Regulatory scrutiny of structure-function claims is increasing. Low-cost substitutes and unverified online sellers pressure pricing. Competition from general supplements and functional foods fragments demand. Brands need rigorous quality control, transparent labeling and clinically supported claims to sustain credibility and veterinary recommendation.

Covid-19 Impact:

The COVID-19 pandemic disrupted veterinary appointments, specialist retail, travel and pet-care supply chains, while shifting more purchasing and advice-seeking online. Some owners postponed non-urgent services, but increased time at home and heightened attention to animal wellbeing supported demand for home-use products and digital support. Providers responded with e-commerce, teleconsultation and flexible scheduling. As restrictions eased, in-person services recovered, but demand for convenience and clear product information remained. The effect varied by market, depending on clinical need, discretionary spending and reliance on in-person experiences where available.

The Live Probiotic Formulas segment is expected to be the largest during the forecast period

The Live Probiotic Formulas segment is expected to account for a leading share of the pet probiotics and postbiotics market during the forecast period. Its position reflects the relevance of this group to the addressable companion-animal population and the breadth of use across the market's principal product type applications. Established product availability, owner familiarity and professional recommendations support demand, while a wide range of care needs encourages repeat purchasing or service use. Market participants are expected to prioritize this segment through targeted product development, broader distribution and clearer use guidance.

The Stool Quality and Gut Recovery segment is expected to have the highest CAGR during the forecast period

The Stool Quality and Gut Recovery segment is expected to have the highest CAGR during the forecast period as providers expand targeted solutions and improve access through veterinary, specialist retail and digital channels. Demand is supported by growing awareness of the relevant need, improved product formulation or service delivery, and increased owner willingness to invest in tailored companion-animal care. As evidence, convenience and availability improve, this segment may attract new entrants and encourage established providers to broaden their portfolios.

Region with largest share:

North America is expected to account for a leading share of the pet probiotics and postbiotics market, supported by high companion-animal ownership, comparatively developed veterinary infrastructure, established pet specialty retail and relatively high per-pet expenditure. The United States represents a major demand center because owners have access to veterinary clinics, online pet-care platforms and a broad selection of specialized products and services. Canada contributes through a mature pet-care ecosystem and established companion-animal health providers. Market adoption is also supported by insurance availability, consumer awareness and product innovation, although adoption differs by income, geography and veterinary access.

Region with highest CAGR:

Asia Pacific is expected to exhibit strong growth in the pet probiotics and postbiotics market as pet ownership, urban household formation, veterinary service availability and organized pet retail expand across major markets. China, Japan, South Korea, India and Australia offer different adoption pathways, reflecting differences in purchasing power, veterinary infrastructure, product regulation and the role of digital commerce. Growing awareness of preventive care and rising demand for premium companion-animal products are likely to support market development. Expansion will depend on localized products, professional education and compliance with national animal-health and consumer-protection requirements.

Key players in the market

Some of the key players in the Global Pet Probiotics and Postbiotics Market include Nestle Purina PetCare (FortiFlora), Nutramax Laboratories, AnimalBiome, Visbiome Vet, VetriScience Laboratories, Zesty Paws, PetLab Co., Native Pet, Fera Pets, Dechra Pharmaceuticals PLC, VetPlus Ltd., Protexin Veterinary, ADM Protexin, Lallemand Animal Nutrition, Bioiberica, ADM Animal Nutrition.

Key Developments:

In September 2026, Standard Process introduced a companion-animal probiotic combining Saccharomyces boulardii, postbiotic metabolites and botanicals for digestive support.

In August 2026, Nestle Purina PetCare introduced a two-step digestive-care kit pairing short-term support with a daily probiotic for dogs and cats experiencing occasional diarrhea.

In April 2026, Nestle Purina PetCare introduced probiotic-powered formulas for adult and senior dogs and cats, including digestive support and senior-focused nutrition.

Product Types Covered:

• Live Probiotic Formulas
• Postbiotic Ingredients
• Synbiotic Blends
• Multi-Strain Microbial Products

Health Applications Covered:

• Digestive Health
• Immune Function
• Microbiome Balance
• Stool Quality and Gut Recovery

Pet Types Covered:

• Dogs
• Cats
• Other Companion Animals

Product Formats Covered:

• Powders and Sachets
• Chews and Tablets
• Liquids and Paste
• Food-Integrated Formulas

Microbial and Active Sources Covered:

• Lactobacillus and Bifidobacterium Strains
• Bacillus and Spore-Forming Strains
• Yeast-Based Probiotics
• Postbiotic Metabolites and Fermentation Products

Evidence Positionings Covered:

• Strain-Specific Clinically Studied Products
• Multi-Strain General Wellness Products
• Veterinary-Recommended Therapeutic Adjuncts
• Emerging Postbiotic Formulations

Distribution Channels Covered:

• Veterinary Clinics and Hospitals
• Specialty Pet Retail
• Online Direct-to-Consumer
• Veterinary and Human-Grade Ingredient Distributors

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
    • Saudi Arabia
    • United Arab Emirates
    • Qatar
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Egypt
    • Morocco
    • Rest of Africa

What our report offers:

• Market share assessments for regional and country-level segments
• Strategic recommendations for new entrants
• Covers market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032, and 2034
• Market trends, including drivers, constraints, opportunities, threats, challenges, investment opportunities, and recommendations
• Strategic recommendations for key business segments based on market estimations
• Competitive landscape mapping and assessment of key industry trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends and assessment of the latest technological advancements

Free Customization Offerings:

All customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, forecasts, and CAGR of any prominent country as per the client's interest (subject to feasibility assessment)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances